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Background: Opportunistic fungi are dispersed as airborne, ground and decaying matter. The second most
frequent extra-pulmonary disease by Aspergillus is in the central nervous system.
Case presentation: The case subject was 55 years old, male, mulatto, and an assistant surveyor residing in Teresina,
Piauí. He presented with headache, seizures, confusion, fever and left hemiparesis upon hospitalization in 2006 at
Hospital São Marcos. Five years previously, he was diagnosed with diabetes mellitus, and 17 months previously he had
acne margined by hyperpigmented areas and was diagnosed with leprosy. Laboratory tests indicated leukocytosis and
magnetic resonance imaging showed an infarction in the right cerebral hemisphere. Cerebrospinal fluid examination
showed 120 cells/mm3 and was alcohol-resistant bacilli negative. Trans-sphenoidal surgery with biopsy showed
inflammation was caused by infection with Aspergillus fumigatus. We initiated use of parenteral amphotericin B,
but his condition worsened. He underwent another surgery to implant a reservoir of Ommaya–Hickmann, a
subcutaneous catheter. We started liposomal amphotericin B 5 mg/kg in the reservoir on alternate days. He was
discharged with a prescription of tegretol and fluconazole.
Conclusion: This report has scientific interest because of the occurrence of angioinvasive cerebral aspergillosis in a
diabetic patient, which is rarely reported. In conclusion, we suggest a definitive diagnosis of cerebral aspergillosis
should not postpone quick effective treatment.
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Opportunistic fungi are dispersed in nature as airborne
particles from soil and mulch [1,2] and infection results
from aspiration of conidia in the air, especially in humid
environments [3]. Aspergillus fumigatus, Aspergillus flavus
and Aspergillus niger species account for 95% of infections
in humans [4]. Aspergillus infection becomes more import-
ant in immunocompromised patients, such as transplanted
patients, human immunodeficiency virus carriers and
patients undergoing cancer treatment [5]. The most com-
mon type of infection is invasive pulmonary aspergillosis* Correspondence: cnsd_ma@uol.com.br
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unless otherwise stated.(80–90%) that can spread to the central nervous system
(CNS) in 10–25% of cases. The second most common
extra-pulmonary disease is that of the CNS [6].
The fungus can reach the brain through the blood by
contiguity through the cribriform walls of the sphenoid
sinus and cavernous sinus, optic nerve or vascular walls,
or by direct implantation through neurosurgery [3]. The
most common characteristic clinical symptoms of infec-
tion are headache, altered mental status and seizures [7].
Patients may manifest seizures or focal neurological signs
from mass effect or stroke [8]. Diagnostics are performed
by imaging and fungus can be measured in cerebrospinal
fluid (CSF) using Sabouraud agar with culture medium
[4,9]. Surgical treatment should be early and aggressive
with the purpose of eliminating most of the necrotic
material via sinus surgery or craniotomy [10].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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This paper presents a case report of invasive aspergillosis of
the CNS with mycotic carotid arteritis. Early diagnosis and
appropriate treatment are essential for a good prognosis.
The case subject was a 55-year-old male, mulatto, who
was an assistant surveyor residing in Teresina (PI). Five
years previously, he was diagnosed with diabetes mellitus
and started on treatment with neutral protamine hagedorn
(NPH) insulin +metformin. During this period, the patient
had one episode of decreased level of consciousness.
Seventeen months previously, he presented with mar-
gined hyperpigmented dermatosis and was diagnosed with
leprosy. He started treatment with dapsone for 14 months.
He reported headaches six months ago, initially related to
sinusitis treated by an otolaryngologist, but then started
having seizures and was transferred to a neurologist who
initiated anticonvulsants. The patient was not involved in
gardening or agricultural activities and he was not a
smoker. The patient worked as an assistant surveyor in
the measurement of land, which could cause potential
exposure to fungi from the air and soil.
Three months previously, he developed mental confu-
sion, fever and left hemiparesis, and was admitted to São
Marcos Hospital on 2 March 2006. He was prescribed
NPH insulin, metformin 850 mg, rocefin 2 g/day, meti-
corten, tegretol 600 mg/day and gardenal 100 mg/day.
Laboratory and imaging tests were conducted. The
hemogram on 2 March 2006 showed leukocytosis was
10.300 cells/mm3, 0.7 mg% creatinine and glucose
160 mg%. Chest X-ray showed pleural thickening with
obliteration of the left costophrenic sinus on 4 March
2006. Computed tomography (CT) and magnetic reson-
ance imaging (MRI) on 9 March 2006 showed right
cerebral hemisphere infarction with hyperemia luxury,
thrombosis of the carotid artery and sphenoid expansive
process with cavernous sinus invasion, meningeal base
and hydrocephalus (Figure 1). Lumbar puncture was
performed with CSF examination (14 March 2006),
which showed 120 cells/mm3, 69% lymphocytes, 49 mg%
protein and 87 mg% glucose with negative alcohol resist-
ant bacilli (BAAR) in the CSF.
After examination, the patient was transferred from the
clinical neurologist to a neurosurgeon, otolaryngologist
and infectologist. He underwent trans-sphenoidal surgery
with biopsy on 4 March 2006, which showed inflamma-
tion and intense infection by Aspergillus fumigatus by
hematoxylin-eosin staining of biopsy samples (Figure 2).
Parenteral liposomal amphotericin B (5 mg/kg/day) treat-
ment was initiated but there was worsening of symptoms
with a decreased level of consciousness after intensification
of convulsive seizures and vomiting. Liposomal amphoteri-
cin B is an alternative for the treatment of choice in some
cases. Here, liposomal amphotericin B was initiated because
of its lower cost compared to voriconazole.A second surgery was performed on 17 May 2006 to im-
plant a subcutaneous Ommaya - Hickmann reservoir and
intra-ventricular catheter. Ventricular CSF was collected
and examination showed 820 cells/mm3, 58% neutrophils,
106 mg% protein and 31 mg% glucose, with negative
culture.
A new cranial CT scan showed right cerebral hemi-
sphere infarction, and a catheter was placed into the right
lateral ventricle and there was a reduction of hydroceph-
alus. Liposomal amphotericin B 5 mg/kg by reservoir
on alternate days was initiated while maintaining NPH
parenteral insulin and tegretol l.600 mg/day. The Infec-
tious Diseases Society (IDSA) guidelines recommend
3–5 mg/kg/day of liposomal amphotericin B for treatment
of cerebral aspergillosis. The scheme was administered on
alternate days because of the patient’s clinical condition
and comorbidities.
The galactomannan test was not performed. Diagnosis
of fungal infection was made by histopathology. Histo-
pathological sections obtained by sphenoid biopsy demon-
strated the presence of septate hyphae with dichotomous
branching, suggesting Aspergillus spp.
There was progressive clinical improvement, seizures
stopped, and the patient awoke, could feed orally and walk,
with support, with reduced left hemiparesis. The patient
was discharged on 14 June 2006 with a prescription of
600 mg/day tegretol + 150 mg fluconazol 2 capsules/day.
Discussion
Aspergillus dissemination to the CNS is a devastating
complication of invasive aspergillosis [11-13]. CNS as-
pergillosis is the most lethal manifestation of Aspergillus
infection with a mortality rate of > 90% [12].
Aspergillus infection often occurs in patients with
weakened immune systems, such as transplant patients,
HIV carriers and patients undergoing cancer treatment
[14]. Other factors of immunosuppression include diabetes
mellitus and leprosy, comorbidities previously shown by
case reports [15]. Although people have contact with a
variety of species of Aspergillus, only seven species are
implicated in human infections. Aspergillus fumigatus
is responsible for about 90% of infections, followed by
Aspergillus flavus [16].
The main route of contamination of the CNS is hema-
togenous dissemination and contiguity from an adjacent
area, such as the orbit or paranasal sinuses [10,17,18]. The
hyphae may block intracerebral blood vessels, promote
infarction that is commonly hemorrhagic and sterile, and
can progress to a septic abscess [9,14,19-22] that promotes
mixed inflammation reactions, necrosis [21,22], vasculitis
and mycotic aneurysms [9,20,22].
There have been few reports of invasive cerebral as-
pergillosis in patients with diabetes [23], indicating the
relevance of this study as the patient had diabetes
Figure 1 Magnetic Resonance Imaging in T1-weighted series of (A) axial, (B) coronal, and (C) sagittal sections. The hyperintense areas in
topography of the right sphenoid sinus are evident in the three images, suggestive of fungal sinusitis. Hyperintense areas in the right superolateral
cortical regions are evident in the three images, suggestive of cerebral infarction with luxury hyperemia by arteritis.
Segundo et al. BMC Research Notes 2014, 7:689 Page 3 of 5
http://www.biomedcentral.com/1756-0500/7/689mellitus and leprosy as factors impairing the immune
system. Oddo and Acuña [24], in a study of 5,612 necrop-
sies, found 175 cases of opportunistic infection, and asper-
gillosis totaled 41 cases (23.4%) ranking second, behind
candidiasis.
Clinical manifestations result from the fungus pathogen-
icity and the host immune response [25]. The presence of
seizures confirms the case reported by Nogales-Gaete
et al. [3]. The diagnosis of aspergillosis is difficult and
complex because of its nonspecific signs and symptoms
[26], and is performed by imaging tests that show changesFigure 2 Histopathological sections obtained by sphenoid biopsy dem
microscopy, suggesting Aspergillus spp. Hematoxylin Eosin (A) magnificthat must then be correlated with clinical, histopatho-
logical and laboratory tests (culture and serology).
Early diagnosis is very important for the management of
mold infections of the CNS to allow for timely therapeutic
intervention and prevention of neurologic sequelae. CT
and MRI are important adjuncts in the detection of infec-
tion and in monitoring the course of therapy [27].
Detection of galactomannan antigen and 1,3-β-dglucan
in CSF can assist in the diagnosis of cerebral aspergillosis
and other mold infections [28,29]. However, as these anti-
gens can also be produced by other species of fungi suchonstrating the presence of septate dichotomous hyphae by
ation is 40× and (B and C) 400× .
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the detection of these antigens do not provide definitive
diagnosis of cerebral aspergillosis [30]. A polymerase-
chain-reaction assay specific for aspergillus might be
useful, but standardized platforms are lacking [31].
There have been few randomized trials on the treatment
of invasive aspergillosis. Most observations of treatment of
CNS aspergillosis are based on open-label studies. One
randomized trial for invasive aspergillosis demonstrated
a trend toward improvement of CNS aspergillosis in
patients treated with voriconazole [32].
Itraconazole, posaconazole, or liposomal amphotericin B
are recommended for patients who are intolerant or refrac-
tory to voriconazole. Among the amphotericins, liposomal
amphotericin B showed favorable responses in some case
reports [33-35], in agreement with the current study.
Nabika et al. [36] reported that surgical reduction of
aspergilloma combined with local administration of anti-
fungal was a good treatment option, corroborating the
present study. According to Pianetti et al. [25], fungal
infections observed as a mass should be treated by aggres-
sive surgical resection. A patient with recurrence may
benefit from the application of intralesional amphotericin
B [37]. There have been few descriptions of patients with
cerebral aspergillosis that survived after undergoing
surgery and antifungal therapy [20,22].
Conclusion
This report has scientific interest because of the occur-
rence of angioinvasive cerebral aspergillosis in a diabetic
patient, findings that are rare in the literature. In conclu-
sion, a definitive diagnosis of cerebral aspergillosis should
not postpone treatment.
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